U.S. flag

An official website of the United States government

NM_001611.5(ACP5):c.613C>T (p.His205Tyr) AND Spondyloenchondrodysplasia with immune dysregulation

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jun 22, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003641101.2

Allele description [Variation Report for NM_001611.5(ACP5):c.613C>T (p.His205Tyr)]

NM_001611.5(ACP5):c.613C>T (p.His205Tyr)

Gene:
ACP5:acid phosphatase 5, tartrate resistant [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_001611.5(ACP5):c.613C>T (p.His205Tyr)
HGVS:
  • NC_000019.10:g.11576365G>A
  • NG_028127.1:g.7622C>T
  • NM_001111034.3:c.613C>T
  • NM_001111035.3:c.613C>T
  • NM_001111036.3:c.613C>T
  • NM_001322023.2:c.613C>T
  • NM_001611.5:c.613C>TMANE SELECT
  • NP_001104504.1:p.His205Tyr
  • NP_001104505.1:p.His205Tyr
  • NP_001104506.1:p.His205Tyr
  • NP_001308952.1:p.His205Tyr
  • NP_001602.1:p.His205Tyr
  • LRG_1218t1:c.613C>T
  • LRG_1218:g.7622C>T
  • LRG_1218p1:p.His205Tyr
  • NC_000019.9:g.11687180G>A
  • NM_001111035.1:c.613C>T
Protein change:
H205Y
Molecular consequence:
  • NM_001111034.3:c.613C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001111035.3:c.613C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001111036.3:c.613C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001322023.2:c.613C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001611.5:c.613C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Spondyloenchondrodysplasia with immune dysregulation (SPENCDI)
Synonyms:
COMBINED IMMUNODEFICIENCY WITH AUTOIMMUNITY AND SPONDYLOMETAPHYSEAL DYSPLASIA; ROIFMAN IMMUNOSKELETAL SYNDROME; SPONDYLOENCHONDRODYSPLASIA WITH OR WITHOUT IMMUNE DYSREGULATION
Identifiers:
MONDO: MONDO:0011939; MedGen: C1842763; OMIM: 607944

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004395694Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Jun 22, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004395694.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change replaces histidine, which is basic and polar, with tyrosine, which is neutral and polar, at codon 205 of the ACP5 protein (p.His205Tyr). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ACP5 protein function. This variant has not been reported in the literature in individuals affected with ACP5-related conditions. This variant is not present in population databases (gnomAD no frequency).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024